Rotterdam, The Netherlands; and the Department of Pathology, Brompton Hospital, London Tuberous sclerosis is a rare disease and pulmonary manifestations are extremely rare. Like pulmonary lymphangioleiomyomatosis, tuberous sclerosis of the lung affects only women of childbearing age and carries a very poor prognosis. The (3-20mm) . Examination of material obtained at biopsy showed emphysematous spaces associated with fibromuscular hyperplasia, compatible with either lymphangioleiomyomatosis or tuberous sclerosis of the lung. Subsequently a discrete facial angiofibroma was found and subependymal calcifications were identified on computed tomography of the brain. There was no retinal phakoma.
Accepted 13 JanuarY 1986 Although the family history was negative, tuberous sclerosis with pulmonary manifestations was diagnosed.
There was progressive deterioration of pulmonary function despite treatment with tamoxifen and later medroxyprogesterone acetate until her death (fig). In January 1983 computed tomography showed enlargment of the spleen, liver, and right kidney. In July she had her twelfth pneumothorax, and in September retroperitoneal bleeding. She died of respiratory failure in November 1983.
Necropsy showed multiple emphysematous spaces in the lung with proliferation of smooth muscle cells in the walls of these spaces. Angiomyolipomas were present in the kidney, spleen, and liver. Examination of the brain was not permitted. PATIENT The deterioration of pulmonary function and the beneficial influence of hormonal treatment in some patients with lymphangioleiomyomatosis led us to attempt treatment of both our patients with tamoxifen (at 36 and 10 weeks respectively) and progesterone (at 69 and 71 weeks respectively). Neither patient benefited and both died of respiratory failure. This could be due to the degree of lung destruction at the start of the treatment, although in other patients with similar pulmonary function hormonal treatment seemed at least to arrest progression.1 7 The steady decline of pulmonary function and the development of new angiomyolipomas during treatment suggest a primary hormonal unresponsiveness. Such 
